NCT01364389View on ClinicalTrials.gov

A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica

PHASE2TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 14, 2011

Primary Completion Date

January 29, 2013

Study Completion Date

January 29, 2013

Conditions
Polymyalgia RheumaticaInflammatory Diseases
Interventions
DRUG

AIN457

3 mg/kg

DRUG

ACZ885

3 mg/kg

DRUG

Prednisone

20 mg

DRUG

Placebo

Matching placebo to AIN457, ACZ885 and prednisone

Trial Locations (6)

13125

Novartis Investigative Site, Berlin

42123

Novartis Investigative Site, Reggio Emilia

53100

Novartis Investigative Site, Siena

55905

Novartis Investigative Site, Rochester

SS16 5NL

Novartis Investigative Site, Basildon

SS0 0RY

Novartis Investigative Site, Westcliff-on-Sea

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY